A randomised controlled unblinded multicentre non-inferiority trial with activated vitamin D and prednisolone treatment in patients with minimal change nephropathy (ADAPTinMCN)

BACKGROUND: Minimal change nephropathy (MCN) is a common cause of nephrotic syndrome in both adults and children. International guidelines recommend treatment with prednisolone 1 mg/kg/day to adults. This dose is derived from an empirically established dose in children, although children generally a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kristensen, Tilde, Birn, Henrik, Ivarsen, Per
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8273943/
https://www.ncbi.nlm.nih.gov/pubmed/34247632
http://dx.doi.org/10.1186/s13063-021-05393-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8273943/
https://www.ncbi.nlm.nih.gov/pubmed/34247632
http://dx.doi.org/10.1186/s13063-021-05393-4

Ejemplares similares